Eliminating hepatitis B virus through neonatal vaccination: Can we make it?

Journal of Hepatology

Volumn 57, Issue 3, 2012, Pages 484-485

  Yeh, Chau Ting ^a   Lai, Ming Wei ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA;

ANTIGENICITY; ANTIVIRAL THERAPY; CHILD CARE; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG POTENCY; EDITORIAL; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNITY; LIVER CELL CARCINOMA; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROLOGY; TREATMENT OUTCOME; VACCINATION; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN;

FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE;

EID: 84865148911     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.06.003     Document Type: Editorial

References (20)

1. Y.H. Ni, L.M. Huang, M.H. Chang, C.J. Yen, C.Y. Lu, and S.L. You Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies Gastroenterology 132 2007 1287 1293
2. M.H. Chang, S.L. You, C.J. Chen, C.J. Liu, C.M. Lee, and S.M. Lin Decreased incidence of hepatocellular carcinoma in hepatitis B vaccines: a 20-year follow-up study J Natl Cancer Inst 101 2009 1348
3. A. Plymoth, S. Viviani, and P. Hainaut Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention Cancer Lett 286 2009 15 21
4. H.Y. Hsu, M.H. Chang, S.H. Liaw, Y.H. Ni, and H.L. Chen Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan Hepatology 30 1999 1312 1317
5. O.C. Jin, C.W. Ning, K. Shiuan, and L.G. Keow Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants J Infect Dis 179 1999 259 263 (Pubitemid 29028367)
6. G. Raimondo, J.P. Allain, M.R. Brunetto, M.A. Buendia, D.S. Chen, and M. Colombo Statements from the Taormina expert meeting on occult hepatitis B virus infection J Hepatol 49 2008 652 657
7. H.M. Hsu, D.S. Chen, C.H. Chuang, J.C. Lu, D.M. Jwo, and C.C. Lee Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers JAMA 260 1988 2231 2235
8. K.V. Tsebe, R.J. Burnett, N.P. Hlungwani, M.M. Sibara, P.A. Venter, and M.J. Mphahlele The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds Vaccine 19 2001 3919 3926 (Pubitemid 32566315)
9. C. He, F. Nomura, S. Itoga, K. Isobe, and T. Nakai Prevalence of vaccine-induced escape mutants of hepatitis B virus in the adult population in China: a prospective study in 176 restaurant employees J Gastroenterol Hepatol 16 2001 1373 1377 (Pubitemid 34107405)
10. H.Y. Hsu, M.H. Chang, Y.H. Ni, and H.L. Chen Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan Gut 53 2004 1499 1503
11. C. Chakvetadze, C. Roussin, J. Roux, V. Mallet, M.E. Petinelli, and S. Pol Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers Vaccine 29 2011 2846 2849
12. S.C. Mu, Y.M. Lin, G.M. Jow, and B.F. Chen Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan J Hepatol 50 2009 264 272
13. L. Xu, Y. Wei, T. Chen, J. Lu, C.L. Zhu, and Z. Ni Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination Vaccine 28 2010 5986 5992
14. S. Shahmoradi, Y. Yahyapour, M. Mahmoodi, S.M. Alavian, Z. Fazeli, and S.M. Jazayeri High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG J Hepatol 57 2012 515 521
15. M. Bes, V. Vargas, M. Piron, N. Casamitjana, J.I. Esteban, and N. Vilanova T cell responses and viral variability in blood donation candidates with occult hepatitis B infection J Hepatol 56 2012 765 774
16. C.W. Hsu, C.T. Yeh, M.L. Chang, and Y.F. Liaw Identification of a hepatitis B virus S gene mutant in Lamivudine-treated patients experiencing HBsAg seroclearance Gastroenterology 132 2007 543 550
17. C.W. Hsu, and C.T. Yeh Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy Hepatology 54 2011 101 108
18. C.J. Clements, B. Coghlan, M. Creati, S. Locarnini, R.S. Tedder, and J. Torresi Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? Bull World Health Organ 88 2010 66 73
19. S. Kamili, V. Sozzi, G. Thompson, K. Campbell, C.M. Walker, and S. Locarnini Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model Hepatology 49 2009 1483 1491
20. M.W. Lai, S.F. Huang, C.W. Hsu, M.H. Chang, Y.F. Liaw, and C.T. Yeh Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy Antivir Ther 14 2009 249 261